Semaglutide online access for South Burlington, Vermont
Company statements checked between September 13, 2026 and September 23, 2026: 3 covered companies — Gentle Health, GoodRx Care and OrderlyMeds — advertise online access to Semaglutide for patients in Vermont, including South Burlington. Confirm eligibility and total charges with the provider.
Browse online Semaglutide programs advertised for patients in South Burlington, Vermont, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded oral semaglutide · Compounded injectable semaglutide | $112/mo advertised monthly bundle, Compounded oral semaglutide | Official site ↗ | |
| GoodRx Care | Wegovy pen · Wegovy HD · Wegovy tablet | $188/mo partial monthly subtotal, Wegovy tablet | Official site ↗ | |
| OrderlyMeds | Wegovy | $1,839/mo advertised monthly bundle, Wegovy | Official site ↗ |
Health context in South Burlington
Semaglutide programs are marketed for weight management and, for some products, type 2 diabetes. These South Burlington figures give local context only. Among the 5 Vermont cities in this research set, South Burlington has the lowest estimate for obesity among adults (22.4%), the lowest estimate for diagnosed diabetes among adults (5.8%), the lowest estimate for high blood pressure among adults (23.2%), the lowest estimate for lack of health insurance among adults aged 18–64 (4.6%) and the highest estimate for routine checkup in the past year among adults (75.4%).
| Measure | South Burlington | 95% range | Among the 5 Vermont cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 22.4% | 19.3–25.7% | lowest | 2023 |
| Diagnosed diabetes among adults | 5.8% | 5–6.6% | lowest | 2023 |
| High blood pressure among adults | 23.2% | 21–25.4% | lowest | 2023 |
| Lack of health insurance among adults aged 18–64 | 4.6% | 3.7–5.5% | lowest | 2023 |
| Routine checkup in the past year among adults | 75.4% | 72.7–77.9% | highest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 20,292); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
This semaglutide page is the South Burlington entry point to the Vermont statewide online listing, not evidence of an office, pharmacy or clinician in South Burlington. Each company below appears because its named products have their own Vermont evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.
Use the Vermont guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.
These are online services advertised for patients in Vermont, listed alphabetically. They are not verified offices, pharmacies or clinicians located in South Burlington, and a listing is not a prescription, appointment or coverage guarantee. Read the Vermont Semaglutide guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's compounded oral and injectable semaglutide programs, if prescribed, billed through its medication-order subscription.
Compounded oral semaglutide (oral): 2–4 mg/day — $112/mo · >4–8 mg/day — $189/mo · >8–12 mg/day — $258/mo
Compounded injectable semaglutide (injection): 0.24–0.48 mg/week — $135/mo · >0.48–1.2 mg/week — $159/mo · >1.2–2.4 mg/week — $199/mo
- Compounded oral semaglutide — oral: state evidence checked · Availability source · Full evidence notes
- Compounded injectable semaglutide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
GoodRx Care
GoodRx Care Direct's separately priced branded semaglutide offers, billed apart from its monthly membership fee.
Wegovy pen (pen): 0.25 and 0.5 mg, first two fills — $238/mo · after the first two fills — $388/mo
Wegovy HD (pen): 7.2 mg — $438/mo
Wegovy tablet (oral tablet): 1.5 mg — $188/mo · 4 mg — $238/mo · higher doses, from — $338/mo
- Wegovy pen — pen: state evidence checked · Availability source · Full evidence notes
- Wegovy HD — pen: state evidence checked · Availability source · Full evidence notes
- Wegovy tablet — oral tablet: state evidence checked · Availability source · Full evidence notes
OrderlyMeds
OrderlyMeds branded Wegovy injection plan.
Wegovy (pen): 0.25, 0.5 or 1 mg (listed strengths) — $1,839/mo
- Wegovy — pen: state evidence checked · Availability source · Full evidence notes
More listings
Other medications for South Burlington: GLP-1 medication access · Tirzepatide
Semaglutide in other Vermont cities: Bennington · Burlington · Essex Junction · Rutland
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.